Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$269.12+0.00 (+0.00%)
Delayed quote: Sep 8, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 8, 2026, 4:00 PM EDT
The latest quarterly tax expense is $1.21 Billion with a quarter-over-quarter change of +60.66%. Income tax expense is the amount a company pays in federal, state, and foreign income taxes based on its taxable income for the period.
Reported quarterly tax expense; no daily interpolation.
$1.21B
$1.21 Billion
+60.66%
vs. $755.00M prior quarter
96
Quarters of data available
| Period | Tax Expense | QoQ Change | % Change |
|---|---|---|---|
| Quarter ended Jun 2026 | $1.21B | +$458.00M | +60.66% |
| Quarter ended Mar 2026 | $755.00M | +$905.00M | +603.33% |
| Quarter ended Dec 2025 | −$150.00M | −$2.49B | -106.41% |
| Quarter ended Sep 2025 | $2.34B | +$1.39B | +145.39% |
| Quarter ended Jun 2025 | $954.00M | −$1.68B | -63.75% |
| Quarter ended Mar 2025 | $2.63B | +$2.18B | +477.19% |
| Quarter ended Dec 2024 | $456.00M | −$188.00M | -29.19% |
| Quarter ended Sep 2024 | $644.00M | −$418.00M | -39.36% |
| Quarter ended Jun 2024 | $1.06B | +$603.00M | +131.37% |
| Quarter ended Mar 2024 | $459.00M | −$235.00M | -33.86% |
| Quarter ended Dec 2023 | $694.00M | −$214.00M | -23.57% |
| Quarter ended Oct 2023 | $908.00M | −$22.00M | -2.37% |
| Quarter ended Jul 2023 | $930.00M | +$1.73B | +216.83% |
| Quarter ended Apr 2023 | −$796.00M | −$1.48B | -216.89% |
| Quarter ended Dec 2022 | $681.00M | −$181.00M | -21.00% |
| Quarter ended Oct 2022 | $862.00M | −$164.00M | -15.98% |
| Quarter ended Jul 2022 | $1.03B | +$313.00M | +43.90% |
| Quarter ended Apr 2022 | $713.00M | +$613.00M | +613.00% |
| Quarter ended Dec 2021 | $100.00M | −$82.00M | -45.05% |
| Quarter ended Oct 2021 | $182.00M | −$202.00M | -52.60% |
| Quarter ended Jul 2021 | $384.00M | −$848.00M | -68.83% |
| Quarter ended Apr 2021 | $1.23B | +$1.32B | +1453.85% |
| Quarter ended Dec 2020 | −$91.00M | −$938.00M | -110.74% |
| Quarter ended Sep 2020 | $847.00M | +$533.00M | +169.75% |
| Quarter ended Jun 2020 | $314.00M | −$399.00M | -55.96% |
| Quarter ended Mar 2020 | $713.00M | +$505.00M | +242.79% |
| Quarter ended Dec 2019 | $208.00M | +$314.00M | +296.23% |
| Quarter ended Sep 2019 | −$106.00M | −$1.54B | -107.39% |
| Quarter ended Jun 2019 | $1.43B | +$761.00M | +113.08% |
| Quarter ended Mar 2019 | $673.00M | +$593.00M | +741.25% |
| Quarter ended Dec 2018 | $80.00M | −$409.00M | -83.64% |
| Quarter ended Sep 2018 | $489.00M | −$530.00M | -52.01% |
| Quarter ended Jul 2018 | $1.02B | −$95.00M | -8.53% |
| Quarter ended Apr 2018 | $1.11B | −$12.16B | -91.61% |
| Quarter ended Dec 2017 | $13.27B | +$12.25B | +1193.66% |
| Quarter ended Oct 2017 | $1.03B | +$105.00M | +11.40% |
| Quarter ended Jul 2017 | $921.00M | −$232.00M | -20.12% |
| Quarter ended Apr 2017 | $1.15B | +$643.00M | +126.08% |
| Quarter ended Dec 2016 | $510.00M | −$499.00M | -49.45% |
| Quarter ended Oct 2016 | $1.01B | +$102.00M | +11.25% |
| Quarter ended Jul 2016 | $907.00M | +$70.00M | +8.36% |
| Quarter ended Apr 2016 | $837.00M | +$294.00M | +54.14% |
| Quarter ended Dec 2015 | $543.00M | −$221.00M | -28.93% |
| Quarter ended Sep 2015 | $764.00M | −$461.00M | -37.63% |
| Quarter ended Jun 2015 | $1.23B | −$30.00M | -2.39% |
| Quarter ended Mar 2015 | $1.25B | +$1.07B | +589.56% |
| Quarter ended Dec 2014 | $182.00M | −$1.88B | -91.17% |
| Quarter ended Sep 2014 | $2.06B | +$761.00M | +58.54% |
| Quarter ended Jun 2014 | $1.30B | +$603.00M | +86.51% |
| Quarter ended Mar 2014 | $697.00M | +$1.47B | +190.64% |
| Quarter ended Dec 2013 | −$769.00M | −$1.45B | -212.26% |
| Quarter ended Sep 2013 | $685.00M | −$275.00M | -28.65% |
| Quarter ended Jun 2013 | $960.00M | +$196.00M | +25.65% |
| Quarter ended Mar 2013 | $764.00M | +$231.00M | +43.34% |
| Quarter ended Dec 2012 | $533.00M | −$433.00M | -44.82% |
| Quarter ended Sep 2012 | $966.00M | +$339.00M | +54.07% |
| Quarter ended Jul 2012 | $627.00M | −$508.00M | -44.76% |
| Quarter ended Apr 2012 | $1.14B | +$1.03B | +1035.00% |
| Quarter ended Dec 2011 | $100.00M | −$809.00M | -89.00% |
| Quarter ended Oct 2011 | $909.00M | +$263.00M | +40.71% |
| Quarter ended Jul 2011 | $646.00M | −$388.00M | -37.52% |
| Quarter ended Apr 2011 | $1.03B | +$748.00M | +261.54% |
| Quarter ended Dec 2010 | $286.00M | −$516.00M | -64.34% |
| Quarter ended Oct 2010 | $802.00M | +$31.00M | +4.02% |
| Quarter ended Jul 2010 | $771.00M | −$983.00M | -56.04% |
| Quarter ended Apr 2010 | $1.75B | +$1.36B | +340.70% |
| Quarter ended Dec 2009 | $398.00M | −$502.00M | -55.78% |
| Quarter ended Sep 2009 | $900.00M | −$155.00M | -14.69% |
| Quarter ended Jun 2009 | $1.05B | −$81.00M | -7.13% |
| Quarter ended Mar 2009 | $1.14B | +$333.00M | +41.47% |
| Quarter ended Dec 2008 | $803.00M | −$177.00M | -18.06% |
| Quarter ended Sep 2008 | $980.00M | −$68.00M | -6.49% |
| Quarter ended Jun 2008 | $1.05B | −$101.00M | -8.79% |
| Quarter ended Mar 2008 | $1.15B | +$1.19B | +2835.71% |
| Quarter ended Dec 2007 | −$42.00M | −$762.00M | -105.83% |
| Quarter ended Sep 2007 | $720.00M | −$230.00M | -24.21% |
| Quarter ended Jul 2007 | $950.00M | −$129.00M | -11.96% |
| Quarter ended Apr 2007 | $1.08B | +$539.00M | +99.81% |
| Quarter ended Dec 2006 | $540.00M | −$361.00M | -40.07% |
| Quarter ended Oct 2006 | $901.00M | +$118.00M | +15.07% |
| Quarter ended Jul 2006 | $783.00M | −$527.00M | -40.23% |
| Quarter ended Apr 2006 | $1.31B | +$855.00M | +187.91% |
| Quarter ended Dec 2005 | $455.00M | −$427.00M | -48.41% |
| Quarter ended Oct 2005 | $882.00M | +$204.00M | +30.09% |
| Quarter ended Jul 2005 | $678.00M | −$410.00M | -37.68% |
| Quarter ended Apr 2005 | $1.09B | −$320.00M | -22.73% |
| Quarter ended Dec 2004 | $1.41B | +$475.00M | +50.91% |
| Quarter ended Sep 2004 | $933.00M | −$44.00M | -4.50% |
| Quarter ended Jun 2004 | $977.00M | −$34.00M | -3.36% |
| Quarter ended Mar 2004 | $1.01B | +$482.00M | +91.12% |
| Quarter ended Dec 2003 | $529.00M | −$348.00M | -39.68% |
| Quarter ended Sep 2003 | $877.00M | +$31.00M | +3.66% |
| Quarter ended Jun 2003 | $846.00M | −$13.00M | -1.51% |
| Quarter ended Mar 2003 | $859.00M | +$394.00M | +84.73% |
| Quarter ended Dec 2002 | $465.00M | −$203.00M | -30.39% |
| Quarter ended Sep 2002 | $668.00M | N/A | N/A |